Drug firm Torrent Pharmaceuticals has launched in India its biosimilar Adalimumab, used for the treatment of auto immune disorders, under the brand name ‘Adfrar’.

New Delhi, Jan 12: Drug firm Torrent Pharmaceuticals has launched in India its biosimilar Adalimumab, used for the treatment of auto immune disorders, under the brand name 'Adfrar'.. The company's ...

The company's product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement. It, however, did not give any details about the price at which the biosimilar ...